Latest news with #KirbyMcInerney
Associated Press
a day ago
- Business
- Associated Press
WST INVESTOR ALERT: Kirby McInerney LLP Notifies West Pharmaceutical Services, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
NEW YORK, June 12, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the July 7, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired West Pharmaceutical Services, Inc. ('West' or the 'Company') (NYSE:WST) securities during the period from February 16, 2023, through February 12, 2025 ('the Class Period'). [LEARN MORE ABOUT THE CLASS ACTION] On February 13, 2025, when West issued extremely weak 2025 revenue and earning forecasts. West attributed the disappointing guidance n part of CM headwinds, including the loss of two major CGM customers that had begun transitioning to in-house manufacturing of next generation devices after West 'made the decision to not participate going forward as our financial thresholds cannot be achieved.' West also revealed that its SmartDose wearable injector devices would be 'margin dilutive' in 2025 and that it would be 'taking steps to improve [its SmartDose] economics, and all options are on the table.' On this news, the price of West shares declined by $123.17 per share, or approximately 38%, from $322.28 per share on February 12, 2025, to close at $199.11 on February 13, 2025. The complaint alleges that defendants, throughout the Class Period, failed to disclose that: (1) despite claiming strong visibility into customer demand and attributing headwinds to temporary COVID-related product destocking, West was in fact experiencing significant and ongoing destocking across its high-margin HVP portfolio; (2) West's SmartDose device, which was purportedly positioned as a high-margin growth product, was highly dilutive to the Company's profit margins due to operational inefficiencies; and (3) these margin pressures created the risk of costly restructuring activities, including the Company's exit from continuous glucose monitoring ('CGM') contracts with long-standing customers. If you purchased or otherwise acquired West securities, have information, or would like to learn more about this investigation, please contact Thomas W. Elrod of Kirby McInerney LLP by email at [email protected], or fill out the form below, to discuss your rights or interests with respect to these matters without any cost to you. [CONTACT FORM] Kirby McInerney LLP is a New York-based plaintiffs' law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm's efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP's website. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Contacts Kirby McInerney LLP Thomas W. Elrod, Esq. 212-699-1180 [email protected]
Business Wire
30-05-2025
- Business
- Business Wire
Kirby McInerney Announces CFTC Whistleblower Award
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is proud to announce that the Commodity Futures Trading Commission (the 'Commission') has awarded approximately $700,000 to a whistleblower it represented. Under the Commodity Exchange Act and the Commission's Whistleblower rules, a whistleblower who provides valuable information is entitled to between 10% and 30% of monetary sanctions collected by the Commission for commodities law violations. The Commission gave the award in recognition that the whistleblower's 'highly significant' information caused the Commission's Division of Enforcement to open an investigation and 'precisely and accurately described' illegal conduct in the commodities markets. The award was also in recognition for the 'high degree of assistance' that the whistleblower provided the Division after the investigation was opened. Ultimately, the Commission concluded that the whistleblower 'conserved substantial resources for the Commission.' 'This case underscores the degree to which whistleblowers can play a critical role in helping regulators police esoteric commodities markets,' said Kirby McInerney Co-Managing Partner David Kovel, who oversaw the case. 'While we disagree with aspects of the CFTC's determination, overall we applaud the CFTC for its support and recognition of whistleblowers, like our client, who bring this important value to the enforcement of commodities markets.' Kirby McInerney extends its gratitude to its client and to the CFTC for investigating and pursuing this case. Kirby McInerney is a New York-based law firm concentrating in whistleblower, securities, antitrust, and consumer litigation. The firm's efforts on behalf of investors, consumers, and the government have resulted in recoveries totaling billions of dollars. The firm represents whistleblowers in numerous programs, including in the SEC, CFTC, and IRS whistleblower programs and in cases under the federal and state False Claims Acts. Kirby McInerney has been involved in some of the most cutting-edge areas of commodities litigation, and represented the whistleblower who received nearly $200 million, the largest CFTC whistleblower award ever. The firm's commodity litigation experience includes cases involving the manipulation of agricultural, energy, fixed income, foreign exchange, metals, and other markets. Notably, Kirby McInerney served as co-lead counsel for a class of exchange-based plaintiffs in the high-profile In re LIBOR-Based Financial Instruments Antitrust Litig., No. 11 MD 2262 (S.D.N.Y.) and secured settlements totaling $190 million for Eurodollar Futures traders. This amount represents the largest recovery in a 'futures-only' commodities class action litigation. Kirby McInerney's CFTC Whistleblower Team is led by the firm's Co-Managing Partner, David Kovel, who was previously a commodities trader for a large financial firm. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Yahoo
30-05-2025
- Business
- Yahoo
Kirby McInerney Announces CFTC Whistleblower Award
NEW YORK, May 30, 2025--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is proud to announce that the Commodity Futures Trading Commission (the "Commission") has awarded approximately $700,000 to a whistleblower it represented. Under the Commodity Exchange Act and the Commission's Whistleblower rules, a whistleblower who provides valuable information is entitled to between 10% and 30% of monetary sanctions collected by the Commission for commodities law violations. The Commission gave the award in recognition that the whistleblower's "highly significant" information caused the Commission's Division of Enforcement to open an investigation and "precisely and accurately described" illegal conduct in the commodities markets. The award was also in recognition for the "high degree of assistance" that the whistleblower provided the Division after the investigation was opened. Ultimately, the Commission concluded that the whistleblower "conserved substantial resources for the Commission." "This case underscores the degree to which whistleblowers can play a critical role in helping regulators police esoteric commodities markets," said Kirby McInerney Co-Managing Partner David Kovel, who oversaw the case. "While we disagree with aspects of the CFTC's determination, overall we applaud the CFTC for its support and recognition of whistleblowers, like our client, who bring this important value to the enforcement of commodities markets." Kirby McInerney extends its gratitude to its client and to the CFTC for investigating and pursuing this case. Kirby McInerney is a New York-based law firm concentrating in whistleblower, securities, antitrust, and consumer litigation. The firm's efforts on behalf of investors, consumers, and the government have resulted in recoveries totaling billions of dollars. The firm represents whistleblowers in numerous programs, including in the SEC, CFTC, and IRS whistleblower programs and in cases under the federal and state False Claims Acts. Kirby McInerney has been involved in some of the most cutting-edge areas of commodities litigation, and represented the whistleblower who received nearly $200 million, the largest CFTC whistleblower award ever. The firm's commodity litigation experience includes cases involving the manipulation of agricultural, energy, fixed income, foreign exchange, metals, and other markets. Notably, Kirby McInerney served as co-lead counsel for a class of exchange-based plaintiffs in the high-profile In re LIBOR-Based Financial Instruments Antitrust Litig., No. 11 MD 2262 (S.D.N.Y.) and secured settlements totaling $190 million for Eurodollar Futures traders. This amount represents the largest recovery in a "futures-only" commodities class action litigation. Kirby McInerney's CFTC Whistleblower Team is led by the firm's Co-Managing Partner, David Kovel, who was previously a commodities trader for a large financial firm. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. View source version on Contacts Kirby McInerney LLPDavid E. Kovel, Esq. 212-371-6600https:// dkovel@ Sign in to access your portfolio
Associated Press
23-05-2025
- Business
- Associated Press
Kirby McInerney LLP Reminds West Pharmaceutical Services, Inc. (WST) Investors of Class Action Filing and Encourages Investors to Contact the Firm
NEW YORK--(BUSINESS WIRE)--May 22, 2025-- The law firm of Kirby McInerney LLP reminds investors who purchased West Pharmaceutical Services, Inc. ('West' or the 'Company') (NYSE:WST) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at [email protected], or fill out the contact form below, to discuss your rights or interests with respect to the securities fraud class action lawsuit against the Company. [CONTACT FORM] The lawsuit was filed on behalf of investors who acquired West securities during the period from February 16, 2023, through February 12, 2025 ('the Class Period'). Investors have until July 7, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit. On February 13, 2025, when West issued extremely weak 2025 revenue and earnings forecasts, West attributed the disappointing guidance in part on CM headwinds, including the loss of two major continuous glucose monitoring ('CGM') customers that had begun transitioning to in-house manufacturing of next generation devices after West 'made the decision to not participate going forward as our financial thresholds cannot be achieved.' West also revealed that its SmartDose wearable injector devices would be 'margin dilutive' in 2025 and that it would be 'taking steps to improve [its SmartDose] economics, and all options are on the table.' On this news, the price of West shares declined by $123.17 per share, or approximately 38%, from $322.28 per share on February 12, 2025, to close at $199.11 on February 13, 2025. The complaint alleges that defendants, throughout the Class Period, failed to disclose that: (1) despite claiming strong visibility into customer demand and attributing headwinds to temporary COVID-related product destocking, West was in fact experiencing significant and ongoing destocking across its high-margin HVP portfolio; (2) West's SmartDose device, which was purportedly positioned as a high-margin growth product, was highly dilutive to the Company's profit margins due to operational inefficiencies; and (3) these margin pressures created the risk of costly restructuring activities, including the Company's exit from CGM contracts with long-standing customers. [LEARN MORE ABOUT THE CLASS ACTION] Kirby McInerney LLP is a New York-based plaintiffs' law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm's efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP's website. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. View source version on CONTACT: Kirby McInerney LLP Thomas W. Elrod, Esq. 212-699-1180 [email protected] KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA NEW YORK INDUSTRY KEYWORD: CLASS ACTION LAWSUIT PROFESSIONAL SERVICES LEGAL SOURCE: Kirby McInerney LLP Copyright Business Wire 2025. PUB: 05/22/2025 08:00 PM/DISC: 05/22/2025 07:59 PM
